Treating anxious expectations can improve dyspnoea in patients with COPD

European Respiratory Journal

Volumn 50, Issue 3, 2017, Pages

  Von Leupoldt, Andreas ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; AVOIDANCE BEHAVIOR; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE BEHAVIORAL THERAPY; COMORBIDITY ASSESSMENT; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; EXPECTATION; FEAR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MORBIDITY; MORTALITY RISK; PERCEPTION; PERSISTENT INFECTION; PHYSICAL ACTIVITY; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PSYCHOLOGICAL WELL-BEING; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; SOCIAL AVOIDANCE BEHAVIOR;

ANXIETY; DYSPNEA; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 85030027370     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01352-2017     Document Type: Review

References (41)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for Diagnosis, Management, and Prevention of COPD. GOLD, 2016.
2. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: Update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185: 435-452.
3. Laviolette L, Laveneziana P. Dyspnoea: A multidimensional and multidisciplinary approach. Eur Respir J 2014; 43: 1750-1762.
4. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: Review and hypotheses. Respir Physiol Neurobiol 2009; 167: 53-60.
5. Johnson MJ, Yorke J, Hansen-Flaschen J, et al. Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J 2017; 49: 1602277.
6. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: Key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: E13-e64.
7. Başoǧlu M. Effective management of breathlessness: A review of potential human rights issues. Eur Respir J 2017; 49: 1602099.
8. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-1185.
9. Vanfleteren LEGW, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 728-735.
10. Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs. Chest 2008; 134: 43S-56S.
11. von Leupoldt A, Kenn K. The psychology of chronic obstructive pulmonary disease. Curr Opin Psychiatry 2013; 26: 458-463.
12. Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev 2014; 23: 345-349.
13. Xu W, Collet J-P, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 2008; 178: 913-920.
14. von Leupoldt A, Taube K, Lehmann K, et al. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest 2011; 140: 730-736.
15. Livermore N, Butler JE, Sharpe L, et al. Panic attacks and perception of inspiratory resistive loads in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178: 7-12.
16. von Leupoldt A, Fritzsche A, Trueba AF, et al. Behavioral medicine approaches to chronic obstructive pulmonary disease. Ann Behav Med Publ Soc Behav Med 2012; 44: 52-65.
17. Smoller JW, Pollack MH, Otto MW, et al. Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. Am J Respir Crit Care Med 1996; 154: 6-17.
18. Troosters T, van der Molen T, Polkey M, et al. Improving physical activity in COPD: Towards a new paradigm. Respir Res 2013; 14: 115.
19. Leeuw M, Goossens MEJB, Linton SJ, et al. The fear-avoidance model of musculoskeletal pain: Current state of scientific evidence. J Behav Med 2007; 30: 77-94.
20. Hayen A, Herigstad M, Pattinson KTS. Understanding dyspnea as a complex individual experience. Maturitas 2013; 76: 45-50.
21. von Leupoldt A, Janssens T. Could targeting disease specific fear and anxiety improve COPD outcomes?. Expert Rev Respir Med 2016; 10: 835-837.
22. Esser RW, Stoeckel MC, Kirsten A, et al. Structural brain changes in patients with COPD. Chest 2016; 149: 426-434.
23. von Leupoldt A, Chan P-YS, Esser RW, et al. Emotions and neural processing of respiratory sensations investigated with respiratory-related evoked potentials. Psychosom Med 2013; 75: 244-252.
24. Faull OK, Jenkinson M, Ezra M, et al. Conditioned respiratory threat in the subdivisions of the human periaqueductal gray. eLife 2016; 27: E12047.
25. Holtz K, Pané-Farré CA, Wendt J, et al. Brain activation during anticipation of interoceptive threat. NeuroImage 2012; 61: 857-865.
26. Paulus MP, Flagan T, Simmons AN, et al. Subjecting elite athletes to inspiratory breathing load reveals behavioral and neural signatures of optimal performers in extreme environments. PloS One 2012; 7: E29394.
27. Stoeckel MC, Esser RW, Gamer M, et al. Amygdala response to anticipation of dyspnea is modulated by 5-HTTLPR genotype. Psychophysiology 2015; 52: 973-976.
28. Stoeckel MC, Esser RW, Gamer M, et al. Brain responses during the anticipation of dyspnea. Neural Plast 2016; 2016: 6434987.
29. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Eur Respir J 2017; 49: 1700214.
30. Carrieri-Kohlman V, Gormley JM, Eiser S, et al. Dyspnea and the affective response during exercise training in obstructive pulmonary disease. Nurs Res 2001; 50: 136-146.
31. Carrieri-Kohlman V, Douglas MK, Gormley JM, et al. Desensitization and guided mastery: Treatment approaches for the management of dyspnea. Heart Lung J Crit Care 1993; 22: 226-234.
32. Janssens T, De Peuter S, Stans L, et al. Dyspnea perception in COPD: Association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest 2011; 140: 618-625.
33. Binks A. Measuring the breathless brain: Is real life too noisy?. Eur Respir J 2015; 46: 1554-1556.
34. Herigstad M, Faull OK, Hayen A, et al. Treating breathlessness via the brain: Changes in brain activity over a course of pulmonary rehabilitation. Eur Respir J 2017; 50: 1701029.
35. Higashimoto Y, Honda N, Yamagata T, et al. Exertional dyspnoea and cortical oxygenation in patients with COPD. Eur Respir J 2015; 46: 1615-1624.
36. Banzett RB, Moosavi SH. Measuring dyspnoea: new multidimensional instruments to match our 21st century understanding. Eur Respir J 2017; 49: 1602473.
37. Donesky D, Nguyen HQ, Paul SM, et al. The affective dimension of dyspnea improves in a dyspnea self-management program with exercise training. J Pain Symptom Manage 2014; 47: 757-771.
38. Wadell K, Webb KA, Preston ME, et al. Impact of pulmonary rehabilitation on the major dimensions of dyspnea in COPD. COPD 2013; 10: 425-435.
39. Evans KC. Cortico-limbic circuitry and the airways: Insights from functional neuroimaging of respiratory afferents and efferents. Biol Psychol 2010; 84: 13-25.
40. Davenport PW, Vovk A. Cortical and subcortical central neural pathways in respiratory sensations. Respir Physiol Neurobiol 2009; 167: 72-86.
41. Livermore N, Dimitri A, Sharpe L, et al. Cognitive behaviour therapy reduces dyspnoea ratings in patients with chronic obstructive pulmonary disease (COPD). Respir Physiol Neurobiol 2015; 216: 35-42.